BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18307411)

  • 1. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semisynthetic Approach to the Analysis of Tumor Suppressor PTEN Ubiquitination.
    Iwase R; Dempsey DR; Whedon SD; Jiang H; Palanski BA; Deng B; Cole PA
    J Am Chem Soc; 2023 Mar; 145(11):6039-6044. PubMed ID: 36897111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.
    Zheng F; Zhong J; Chen K; Shi Y; Wang F; Wang S; Tang S; Yuan X; Shen Z; Tang S; Xia D; Wu Y; Lu W
    J Exp Clin Cancer Res; 2023 Nov; 42(1):295. PubMed ID: 37940999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
    Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
    J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ligase HERC5 promotes antimycobacterial responses in macrophages by ISGylating the phosphatase PTEN.
    Du X; Sheng J; Chen Y; He S; Yang Y; Huang Y; Fu Y; Lie L; Han Z; Zhu B; Liu H; Wen Q; Zhou X; Zhou C; Hu S; Ma L
    Sci Signal; 2023 Jun; 16(788):eabm1756. PubMed ID: 37279284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer.
    Xu L; Xiang W; Yang J; Gao J; Wang X; Meng L; Ye K; Zhao XH; Zhang XD; Jin L; Ye Y
    J Exp Clin Cancer Res; 2024 Jan; 43(1):17. PubMed ID: 38200519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nedd4 branches out.
    DiAntonio A
    Neuron; 2010 Feb; 65(3):293-4. PubMed ID: 20159442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Proteomics-Based Approach Identifies the NEDD4 Adaptor NDFIP2 as an Important Regulator of Ifitm3 Levels.
    Marziali F; Song Y; Nguyen XN; Belmudes L; Burlaud-Gaillard J; Roingeard P; Couté Y; Cimarelli A
    Viruses; 2023 Sep; 15(10):. PubMed ID: 37896772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering PTEN function: membrane association and activity.
    Yang JM; Nguyen HN; Sesaki H; Devreotes PN; Iijima M
    Methods; 2015 May; 77-78():119-24. PubMed ID: 25448479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome changes induced by expression of tumor suppressor PTEN.
    Kim SY; Kim YS; Bahk YY
    Mol Cells; 2003 Jun; 15(3):396-405. PubMed ID: 12872999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and yeast 2-hybrid screens to identify PTEN binding partners.
    Tibarewal P; Spinelli L; Maccario H; Leslie NR
    Adv Biol Regul; 2024 Jan; 91():100989. PubMed ID: 37839992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Look for the Scaffold: Multifaceted Regulation of Enzyme Activity by 14-3-3 Proteins.
    Obšilová V; Obšil T
    Physiol Res; 2024 Apr; ():. PubMed ID: 38647170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review).
    Alrosan AZ; Alrosan K; Heilat GB; Alsharedeh R; Abudalo R; Oqal M; Alqudah A; Elmaghrabi YA
    Mol Clin Oncol; 2023 Sep; 19(3):68. PubMed ID: 37614371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of chronic intracellular infection with
    Guo X; Zeng H; Li M; Xiao Y; Gu G; Song Z; Shuai X; Guo J; Huang Q; Zhou B; Chu Y; Jiao H
    Front Cell Infect Microbiol; 2023; 13():1129172. PubMed ID: 37143745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
    Jayaprakash S; Hegde M; BharathwajChetty B; Girisa S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Phosphoinositide 3-Kinase-Akt (PI3K-Akt) Pathway in the Pathogenesis of Alzheimer's Disease.
    Kumar M; Bansal N
    Mol Neurobiol; 2022 Jan; 59(1):354-385. PubMed ID: 34699027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome-(phospho)proteome characterization of brain of a germline model of cytoplasmic-predominant Pten expression with autism-like phenotypes.
    Thacker S; Eng C
    NPJ Genom Med; 2021 Jun; 6(1):42. PubMed ID: 34078911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.
    Shaji SK; Sunilkumar D; Mahalakshmi NV; Kumar GB; Nair BG
    Oncol Lett; 2019 Aug; 18(2):1938-1948. PubMed ID: 31423264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN and NEDD4 in Human Breast Carcinoma.
    Chen Y; van de Vijver MJ; Hibshoosh H; Parsons R; Saal LH
    Pathol Oncol Res; 2016 Jan; 22(1):41-7. PubMed ID: 26276352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosome-mediated delivery of the intrinsic C-terminus domain of PTEN protects it from proteasomal degradation and ablates tumorigenesis.
    Ahmed SF; Das N; Sarkar M; Chatterjee U; Chatterjee S; Ghosh MK
    Mol Ther; 2015 Feb; 23(2):255-69. PubMed ID: 25327178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.